Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome
- PMID: 33766722
- PMCID: PMC8277706
- DOI: 10.1016/j.ntt.2021.106975
Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome
Abstract
The opioid epidemic in the United States has led to a significant increase in the incidence of neonatal opioid withdrawal syndrome (NOWS); however, the understanding of long-term consequences of NOWS is limited. The objective of this study was to evaluate post-discharge healthcare utilization in infants with NOWS and examine the association between NOWS severity and healthcare utilization. A retrospective cohort design was used to ascertain healthcare utilization in the first year after birth-related discharge using the CERNER Health Facts® database. ICD-9/ICD-10 diagnostic codes were used to identify live births and to classify infants into two study groups: NOWS and uncomplicated births (a 25% random sample). Evaluated outcomes included rehospitalization, emergency department (ED) visits within 30-days and one-year after discharge, and a composite one-year utilization event (either hospitalization or emergency department visit during that year). NOWS severity was operationalized as pharmacologic treatment, length of hospitalization, and medical conditions often associated with NOWS. In 3,526 infants with NOWS (restricted to gestational age ≥ 33 weeks), NOWS severity was associated with an increase in composite one-year utilization (OR: 1.1; 95% CI: 1.04-1.2) after adjusting for prematurity, sepsis, jaundice, use of antibiotics, infant sex, insurance status, race, hospital bed size, year of birth, and census division. In a subset of full-term infants (3008 with NOWS and 88,452 uncomplicated births), having a NOWS diagnosis was associated with higher odds of a 30-day (OR: 1.6; 95% CI: 1.03-2.4) and one-year rehospitalization (OR: 1.6; 95% CI: 1.1-2.4) after adjusting for infant sex, race, type of medical insurance, hospital location, census division, year of primary encounter, hospital bed size, and medical conditions. This study found higher healthcare utilization during the first year of life in infants diagnosed with NOWS, especially those with severe NOWS. Findings suggest a need for closer post-discharge follow-up and management of infants with NOWS.
Keywords: Healthcare utilization; Hospitalizations; Infants; Neonatal opioid withdrawal syndrome; Opioids; Pregnancy.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Hospital Readmissions Among Infants With Neonatal Opioid Withdrawal Syndrome.JAMA Netw Open. 2024 Sep 3;7(9):e2435074. doi: 10.1001/jamanetworkopen.2024.35074. JAMA Netw Open. 2024. PMID: 39316398 Free PMC article.
-
Sex-Related Differences in the Severity of Neonatal Opioid Withdrawal Syndrome: A Single-Center, Retrospective Cohort Study.Am J Perinatol. 2025 Feb;42(3):363-368. doi: 10.1055/s-0044-1788717. Epub 2024 Jul 29. Am J Perinatol. 2025. PMID: 39074806
-
Healthcare utilization among children with a history of neonatal opioid withdrawal syndrome: A matched cohort study.Child Abuse Negl. 2022 Dec;134:105934. doi: 10.1016/j.chiabu.2022.105934. Epub 2022 Oct 24. Child Abuse Negl. 2022. PMID: 36302288
-
Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.Neurotoxicol Teratol. 2021 Nov-Dec;88:107020. doi: 10.1016/j.ntt.2021.107020. Epub 2021 Aug 19. Neurotoxicol Teratol. 2021. PMID: 34419619 Free PMC article. Review.
-
Clinical care of neonates undergoing opioid withdrawal in the immediate postpartum period.Neurotoxicol Teratol. 2021 Jul-Aug;86:106978. doi: 10.1016/j.ntt.2021.106978. Epub 2021 Apr 7. Neurotoxicol Teratol. 2021. PMID: 33838247 Review.
Cited by
-
Delivery timing for the opioid-exposed infant.Am J Obstet Gynecol MFM. 2022 Nov;4(6):100719. doi: 10.1016/j.ajogmf.2022.100719. Epub 2022 Aug 15. Am J Obstet Gynecol MFM. 2022. PMID: 35977700 Free PMC article.
-
Call to Action: Standardizing Follow-Up Care for Infants Prenatally Exposed to Opioids.Hosp Pediatr. 2025 Mar 1;15(3):e121-e125. doi: 10.1542/hpeds.2024-008094. Hosp Pediatr. 2025. PMID: 39914459 Free PMC article.
-
Acupuncture for neonatal abstinence syndrome in newborn infants.Cochrane Database Syst Rev. 2025 Feb 21;2(2):CD014160. doi: 10.1002/14651858.CD014160.pub2. Cochrane Database Syst Rev. 2025. PMID: 39981752
-
Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome.Sci Rep. 2022 Apr 8;12(1):5941. doi: 10.1038/s41598-022-09793-7. Sci Rep. 2022. PMID: 35396369 Free PMC article.
-
Association between pharmacologic treatment and hospital utilization at birth among neonatal opioid withdrawal syndrome mother-infant dyads.J Perinatol. 2023 Mar;43(3):283-292. doi: 10.1038/s41372-023-01623-6. Epub 2023 Jan 30. J Perinatol. 2023. PMID: 36717607
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources